摘要
中药源于天然,富含多种活性成分,临床和实验研究表明,一些中药、复方及中药单体可能通过多靶点在体内发挥调脂作用,有一定研发和应用价值。但目前调脂中药的临床研究较多的局限于生化指标的调节,且样本量小,可重复性差,缺乏多中心、大样本随机对照试验研究,更缺乏心脑血管不良事件的远期随访。应通过科学研究让中医药的综合调理优势得以在调节血脂过程中发挥出来。
Summary:The traditional Chinese medicines come from natural and include many kinds of active ingredients. The clinical and experimental studies indicate that some traditional Chinese medicines (including the compound and the monomer) may regulate the lipid on multi-targets in vivo, which has certain value in only research and application. Present clinical researches on traditional Chinese medicines for lipid-regulation are limited in only regulating biochemistry level, small samples, poor repeatability, short of multi-central large-sample random-control experiments and absence of long term follow-up on cardiovascular and cerebrovascular adverse events. We should take the advantage of traditional Chinese medicine superiority in lipid-regulating process by scientific researches.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2009年第1期10-12,共3页
Chinese Journal of Practical Internal Medicine
关键词
降血脂药
高脂血症
中医药
antilipemic agents
hyperlipidemia
traditional Chinese medicine